Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions.

Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Abstract Text:

M Trakatelli,C Ulrich,V del Marmol,S Euvard,E Stockfleth,D Abeni,M Trakatelli,C Ulrich,V del Marmol,S Euvard,E Stockfleth,D Abeni,M Trakatelli,C Ulrich,V del Marmol,S Euvrard,S Euvard,E Stockfleth,D Abeni,

Nonmelanoma skin cancer (NMSC) is the most common malignancy occurring in white populations. It is currently becoming an important challenge in terms of public health management as the increasing incidence rates will probably have a tremendous impact on healthcare costs. Possible factors driving this rise in NMSC numbers are increases in both acute and prolonged UV exposure together with increasing numbers of older people in the population. A better understanding of NMSC epidemiology in Europe is essential if an evidence-based European-wide public health policy is to be developed. It is obvious this can only be achieved by recording and analysing comparative epidemiological data. Finally, by improving the skin examination training for physicians, developing guidelines and exchanging best practices, a high level of healthcare could be provided for NMSC.

Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Publishing Authors By Initials

M Trakatelli,C Ulrich,V del Marmol,S Euvard,E Stockfleth,D Abeni,M Trakatelli,C Ulrich,V del Marmol,S Euvard,E Stockfleth,D Abeni,M Trakatelli,C Ulrich,V del Marmol,S Euvrard,S Euvard,E Stockfleth,D Abeni,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: The British journal of dermatology

VOLUME: 156 Suppl 3

Page Numbers: 1-7

Journal Abbreviation: Br. J. Dermatol.

ISSN: 0007-0963

DAY: 9

MONTH: May

YEAR: 2007

Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 4041

Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions.

AFFILIATION: Department of Dermatology, Aristotle University School of Medicine, Thessaloniki, Greece. mtrakatelli@hotmail.com

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Epidemiology of nonmelanoma skin cancer NMSC in Europe: accurate and comparable data are needed for effective public health monitoring and interventions Related Publications

• Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
• Can cognitive-behavioral therapy help patients with vitiligo?
• Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions.
• Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals.
• Identification of categories at risk for high quality of life impairment in patients with vitiligo.
• Measuring the health status of patients with vascular leg ulcers and the burden for their caregivers.
• Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis.
• The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire.
• The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study.